Loading LFCR charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading LFCR comparable companies…
| LFCRLifecore Biomedical, Inc.(opens in a new tab) | $0.24B | — | — | — | — | — | — |
|---|---|---|---|---|---|---|---|
| ZVRAZevra Therapeutics, Inc.(opens in a new tab) | $0.63B | $0.14B | +119.4% | 95.5% | 60.5% | 4.64× | 11.2× |
| GYREGyre Therapeutics, Inc.(opens in a new tab) | $0.46B | $0.12B | +13.5% | 94.3% | −14.0% | 3.84× | — |
| SPRYARS Pharmaceuticals, Inc.(opens in a new tab) | $0.33B | $0.12B | +4.1% | 100.0% | −185.0% | 2.86× | — |
| KPTIKaryopharm Therapeutics Inc.(opens in a new tab) | $0.00B | $0.15B | +6.8% | — | −56.2% | 0.00× | — |
| Medianpeers, excl. LFCR | $0.40B | $0.13B | +10.2% | 95.5% | −35.1% | 3.35× | 11.2× |